Beta-lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci - Hirano,L.; Bayer,A.S. (Antimicrob Agents Chemother, 1991)